The war has caused "imminent danger" to the country's energy supplies, President Ferdinand Marcos Jr says.

A Bay Area biotech company saw its obesity drug fail in clinical trials just five months ago. Now it's being acquired for nearly $7 billion after shifting its focus to a different disease.

From startup to a potential $2.2 billion buyout within a year: How a big deal could pay off for patients, a young company and ...

JavaOne Oracle has shipped Java 26, a short-term release, and introduced Project Detroit, which promises faster interop between Java, JavaScript, and Python. Java 26 will be supported for just six ...

US senators grill fellow Senator Markwayne Mullin at his confirmation hearing to become the new leader of the Department of ...

The Carney government is promising more than $37 million in humanitarian aid for civilians in Lebanon caught in the crossfire ...

Neither Republican senators, who made the latest offer to end a funding impasse, nor Democrats, who are demanding more ...

Can you scream your way to happiness? Maybe not, but the scream clubs popping up around the U.S. promise some relief. Manny ...

As Waymo expands, experts say autonomous cars still struggle with the unpredictability and social norms of real-world driving ...

Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today ...